The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study.
 
Paolo Ghia
Honoraria - Abbvie; AstraZeneca; BeiGene; Galapagos NV; Gilead Sciences; Janssen Oncology; Juno/Celgene/Bristol-Myers Squibb; Lilly; MSD; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Galapagos NV; Janssen; Lilly; MSD; Roche
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene/Juno (Inst); Janssen Oncology; Lilly
 
Paul Barr
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Genentech; Infinity Pharmaceuticals; Janssen; MEI Pharma; Merck; MorphoSys; Novartis; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - AstraZeneca (Inst); Pharmacyclics (Inst)
 
John Allan
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Epizyme; Genentech; Janssen; Pharmacyclics; TG Therapeutics
Speakers' Bureau - Abbvie; BeiGene; Janssen; Pharmacyclics
Research Funding - BeiGene; Celgene; Genentech; Janssen; TG Therapeutics
 
Tanya Siddiqi
Honoraria - AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Celgene; Kite, a Gilead company
Research Funding - Acerta Pharma (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb/Sanofi (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Alessandra Tedeschi
Employment - Abbvie; BeiGene; J&J; Lilly
Consulting or Advisory Role - Abbvie; AstraZeneca; Beigene; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Beigene; Janssen
 
Thomas Kipps
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie; Genentech/Roche; Oncternal Therapeutics; Pharmacyclics
 
Susan O'Brien
Employment - University of California, Irvine
Honoraria - Abbvie; Amgen; Caribou Biosciences; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Pfizer; Pharmacyclics; Secura Bio; TG Therapeutics; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Caribou Biosciences; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Pfizer; Pharmacyclics; Secura Bio; TG Therapeutics; Vaniam Group
Research Funding - Caribou Biosciences (Inst); MustangBio (Inst); Nurix (Inst); Pharmacyclics (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Abbvie/Genentech; Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron
 
Ryan Jacobs
Consulting or Advisory Role - Abbvie; AstraZeneca; Pharmacyclics; Verastem
Speakers' Bureau - Abbvie; Astrazeneca; BeiGene; Janssen; Pharmacyclics
Research Funding - MEI Pharma; Pharmacyclics; TeneoBio; TG Therapeutics
 
Xavier Badoux
Honoraria - Abbvie; Janssen
Travel, Accommodations, Expenses - Abbvie
 
Livio Trentin
No Relationships to Disclose
 
Masa Lasica
No Relationships to Disclose
 
Dennis Carney
No Relationships to Disclose
 
Anna Elinder Camburn
Consulting or Advisory Role - Abbvie; Janssen
 
Javier De La Serna Torroba
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Janssen
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
 
Edith Szafer-Glusman
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Cathy Zhou
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jutta Neuenburg
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
James Dean
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
William Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Bristol-Myers Squibb; Cyclacel; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Kite, a Gilead company; Loxo; MDACC Cancer Center Support Grant; NIH/NCI award number CA016672; Novartis; Numab; Nurix; Oncternal Therapeutics, Inc; Pharmacyclics; Xencor
 
Constantine Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)